Pages that link to "Q46213374"

The following pages link to Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. (Q46213374):

Displaying 24 items.

• Transglutaminases: nature's biological glues (Q24534936) (← links)
• Targeting innate immunity for neurodegenerative disorders of the central nervous system (Q26744219) (← links)
• Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block (Q26824549) (← links)
• Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death (Q28069852) (← links)
• Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. (Q30997344) (← links)
• Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine (Q33292114) (← links)
• Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries (Q33370734) (← links)
• Intracellular localization and conformational state of transglutaminase 2: implications for cell death (Q33476870) (← links)
• Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium (Q35182047) (← links)
• Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease (Q37176469) (← links)
• Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. (Q37266151) (← links)
• Transglutaminase activation in neurodegenerative diseases. (Q37352964) (← links)
• Transglutaminases and neurodegeneration (Q37365083) (← links)
• D-Ribosylated Tau forms globular aggregates with high cytotoxicity (Q39839548) (← links)
• Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy. (Q40354154) (← links)
• Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation (Q40403566) (← links)
• The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase (Q41418352) (← links)
• Are tau aggregates toxic or protective in tauopathies? (Q42024199) (← links)
• Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease. (Q42026368) (← links)
• Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease. (Q43275673) (← links)
• New Insights into Transglutaminase 2 and Links to Neurodegenerative Diseases (Q47350887) (← links)
• Amyloidogenesis of Tau protein (Q47718633) (← links)
• Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice. (Q49084035) (← links)
• Progressive supranuclear palsy (Q77296589) (← links)